Royalty Pharma declares fourth-quarter dividend of $0.235 per Class A share

• Royalty Pharma declared a fourth-quarter 2026 dividend of $0.235 per Class A ordinary share.
• Payment is due December 10, 2026, to shareholders of record at the close of business on November 13, 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Royalty Pharma plc published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610160800PRIMZONEFULLFEED9847071) on October 16, 2026, and is solely responsible for the information contained therein.